We're inviting the cancer research community to join us in Dublin, Ireland on 27 - 29 Feb 2024 for an inspiring event covering the latest findings in basic and translational cancer research.
If you'd like to promote EACR-AACR-IACR 2024 through your communication channels, such as social media, email lists, websites, and newsletters, you can help us reach a wider audience and attract more participants. The more people hear about the conference, the more impact we can make in advancing cancer research.
To make it easy for you to promote the conference, you can use the below materials:
These are just some examples of short and catchy messages that you can share on your social media accounts, using the official Congress hashtag #EAISciencetoClinic. You can also tag the EACR accounts on Twitter, LinkedIn, Facebook and Instagram.
Don't miss the EACR-AACR-IACR 2024 Basic and Translational Research conference in Dublin! It's the perfect opportunity to connect with leading cancer researchers, attend engaging sessions, and build valuable networks. #EAISciencetoClinic
Join the conversation on cancer research at the EACR-AACR-IACR 2024! With top-notch speakers, exciting sessions, and vibrant networking opportunities, this is the event you don't want to miss. #EAISciencetoClinic
Feel free to use these eye-catching graphics on your website, social media or newsletter to promote the Congress. You can choose from different sizes and formats, depending on your needs.
Travel Grant Application Deadline
02 October 2023
Abstract Submission Deadline
16 October 2023
Early Rate Registration Deadline
06 December 2023
Regular Rate Registration Deadline
26 January 2024
Above: colourful Dublin, where our conference will take place
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.